Dian Diagnostics and Vision Medicals Sign Strategic Cooperation Agreement on mNGS Infection Diagnostics
On September 10, Dian Diagnostics and Vision Medicals signed a strategic cooperation agreement in Hangzhou.
The two parties will carry out in-depth cooperation on integrated mNGS (metagenomic sequencing) services for infection diagnostics, jointly promoting the compliant, standardized and large-scale application of mNGS technology in the field of precision diagnosis and treatment of infectious diseases in China.
Why this event matters
The event has a measured impact on 2 industrys. The strongest current signal is positive for Pharmaceutical R&D Services, with intensity 40/100 and 70% confidence over a medium term horizon.
Healthcare · 13.15
Pharmaceutical R&D Services
- Direction
- positive
- Intensity
- 40
- Confidence
- 70%
- Horizon
- Medium term
Biotechnology
- Direction
- positive
- Intensity
- 35
- Confidence
- 65%
- Horizon
- Medium term
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.